Last reviewed · How we verify

NCT05263518

Influence of Different Toric Intraocular Lenses on IOL-capsular Complex

Status unknown NA Last updated 19 April 2022
What this trial tests

NA trial testing Cataract surgery with AcrySof IQ IOL implantation. in Corneal Astigmatism in 100 participants. Status unknown.

Timeline
1 May 2022
Primary endpoint
1 September 2022
1 December 2022

Quick facts

Lead sponsorWenzhou Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment100
Start date1 May 2022
Primary completion1 September 2022
Estimated completion1 December 2022

Drugs / interventions tested

Conditions studied

Sponsor

Wenzhou Medical University

Who can join

Adults 50 to 90, any sex, with Corneal Astigmatism or Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Corneal astigmatism is refractive error that impairs uncorrected visual acuity. When patients undergo cataract surgery, implantation of toric IOL is deemed the most effective choice for correcting corneal astigmatism and reducing postoperative spectacle dependence. The IOL-capsular complex is formed after cataract surgery and intraocular lens (IOL) implantation. Early postoperative mechanical wrapping of the anterior and posterior capsules plays a significant role in preventing IOL decentration and tilt, as well as formation of the IOL-capsular complex which reduces the incidence of posterior cataract opacity. IOL decentration ≥ 0.4 mm or/and IOL tilt ≥7degree were considered clinically significant because of poor post-surgery visual quality especially for optical sophisticated IOLs such as toric IOLs. IOL instability could decrease the curative effect of toric IOL. There are numerous types of toric IOLs; however, AcrySof IQ and TECNIS toric IOL are most frequently used in the Ophthalmology Hospital of Wenzhou Medical University. AcrySof IQ IOL has some differences compared with TECNIS toric IOL. IQ has a modified L haptic design while TECNIS® toric IOL has a modified C haptic design. AcrySof IQ IOL has a discontinuous 360˚ posterior square edge while TECNIS toric IOL has a continuous 360˚ posterior square edge. The AcrySof IQ IOL cylinder power models include 1.00, 1.50, 2.25, 3.00, 3.75, 4.50, 5.25 and 6.00 D. The Tecnis IOL cylinder power models include 1.00, 1.50, 2.25, 3.00 and 4.00 D. Previous study pointed that patients with cataracts with corneal astigmatism achieved comparable improvement in visual acuity, astigmatism correction, CS(sensitive contrast), rotational stability and satisfaction, following AcrySof and TECNIS toric IOL implantation. However,some other studies found that the Acrysof toric IOL showed significantly greater rotational stability than the Tecnis toric IOL and the rate of surgical IOL repositioning was higher in eyes implanted with TECNIS than with AcrySof toric IOLs for astigmatic correction. Currently, there is no literature guidance to compare the results of cataract surgery combined various types of toric IOLs implantation in patients using CASIA2. The novel anterior segment optical coherence tomography (AS-OCT) device, CASIA2 can accurately evaluate the IOL capsule bending and the lens position after cataract surgery. Also, CASIA2 can be used to documented the dynamic changes of IOL-capsular complex after surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of the effect of capsular bend on the rotational stability between 2 toric intraocular lenses.
    Wang Y, Lou X, Qian S, Li Y, et al · · 2024 · cited 4× · PMID 38085243 · DOI 10.1097/j.jcrs.0000000000001373

Verify or expand the search:

Other recruiting trials for Corneal Astigmatism

Currently open trials in the same condition.

Other Wenzhou Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05263518.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing